Company Secretary Change (8541A)

TIDMHIK

RNS Number : 8541A

Hikma Pharmaceuticals Plc

04 April 2012

Company Secretary

London, 4 April 2012 - Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK) ("Hikma"), the FTSE 250 pharmaceuticals company, announces the appointment of Mr. Peter Speirs as Company Secretary of Hikma with effect from 3 April 2012. Mr. Henry Knowles continues in his role as the Group General Counsel of the Company.

- ENDS -

Enquiries:

Hikma Pharmaceuticals PLC

   Peter Speirs, Company Secretary                                 +44 (0)20 7399 2760 
   Susan Ringdal, Director of Investor Relations                  +44 (0)20 7399 2760

About Hikma

Hikma is a fast growing multinational pharmaceutical group focused on developing, manufacturing and marketing a broad range of both branded and non--branded generic and in--licensed products. Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics" based principally in the Middle East and North Africa ("MENA") region, where it is a market leader, the United States and Europe. In 2011, Hikma achieved revenue of $918.0 million and profit attributable to shareholders of $80.1 million.

This information is provided by RNS

The company news service from the London Stock Exchange

END

COSLLFIESFISIIF

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024